Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

HC Wainwright & Co. Downgrades CytoSorbents to Neutral, Lowers Price Target to $1

Author: Benzinga Newsdesk | December 29, 2023 11:48am
HC Wainwright & Co. analyst Sean Lee downgrades CytoSorbents (NASDAQ:CTSO) from Buy to Neutral and lowers the price target from $5.5 to $1.

Posted In: CTSO

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist